Skip to content
ClinicalEvidence

Pharma competitive intelligence tools for clinical pipelines

ClinicalEvidence is a pharma competitive intelligence tool for the clinical side of the pipeline. Ask which competing programs run in an indication and it answers from ClinicalTrials.gov, the EU Clinical Trials Register, WHO ICTRP and PubMed, with an NCT number or PMID behind every sentence, a filterable trial table and alerts on new trials. Plans start at 49 USD per month, not an enterprise contract.

Every sentence cited to an NCT number or PMID. Professional use, no patient data needed.

Most competitive intelligence budgets go to a database you query twice a month

Pharma competitive intelligence covers pipelines, deals, patents, sales forecasts and trials. The established vendors sell all of it as one enterprise license, which makes sense for a large company with a dedicated CI function and makes little sense for a clinical lead who needs to know what the three closest rivals registered last month.

The clinical part of the question is narrower than the product suggests:

  • Which programs are running in this indication, at what phase, and who sponsors them?
  • What endpoints, comparators and sample sizes did they register?
  • Did a status change, a new country or a new trial appear since the last review?
  • Which published results back the claims in a rival's press release?

That is registry and literature work, and it is the work ClinicalEvidence is built for. It does not replace deal tracking or sales forecasting. It replaces the hours spent rebuilding the same trial list by hand before each steering meeting.

Where each kind of competitive intelligence tool fits

Categories are described from general knowledge of the market. Pricing for enterprise platforms is quoted by the vendor, so confirm current terms before you decide.

Best at

Enterprise pharma intelligence platforms
Pipelines, deals, forecasts and trial data in one licensed database
Free registry websites
Raw records for one registry at a time
ClinicalEvidence
Cited answers on competing trials across three registries and PubMed

Trial coverage

Enterprise pharma intelligence platforms
Curated trial records, often enriched by analysts
Free registry websites
One registry per site, inconsistent fields
ClinicalEvidence
ClinicalTrials.gov, EU CTR and WHO ICTRP, index refreshed daily

Citations

Enterprise pharma intelligence platforms
Source links per record
Free registry websites
The record itself
ClinicalEvidence
Every sentence cited to an NCT number or PMID and checked before display

Alerts

Enterprise pharma intelligence platforms
Yes, by contract tier
Free registry websites
Limited or none
ClinicalEvidence
Alerts on new trials and status changes for a saved question

Deals, patents, sales forecasts

Enterprise pharma intelligence platforms
Yes
Free registry websites
No
ClinicalEvidence
No

Price

Enterprise pharma intelligence platforms
Contract, not published
Free registry websites
Free but manual
ClinicalEvidence
Clinician 49 USD monthly (24 billed yearly); Research Team 199 USD monthly (99 billed yearly)

Seats

Enterprise pharma intelligence platforms
Negotiated
Free registry websites
Not applicable
ClinicalEvidence
Research Team 3 seats, Organization 10, Enterprise up to 50, answers pooled

Best for

Enterprise pharma intelligence platforms
A dedicated CI department with a broad remit
Free registry websites
Looking up a single known trial
ClinicalEvidence
Clinical, BD and medical teams that need rival trial evidence on demand

Keep the enterprise platform if you need deals and forecasts. If the daily question is "what is registered against us in this indication", a cited registry tool is faster and far cheaper. For one specific product comparison see the Trialtrove alternative page.

From a rival question to a cited pipeline table

Type the question the way a colleague would ask it. ClinicalEvidence reads the registries and papers and shows its sources.

  1. Ask about an indication or a rival drug. The clinical trial search covers three registries and PubMed in one pass.

  2. Read the answer. Each sentence carries an NCT number or PMID, and each citation is verified against its source. No verified source, no answer.

  3. Open the trial table and filter by phase, status, sponsor type, country and enrollment.

  4. Save the question and turn on alerts so new rival trials and status changes reach the team by email.

  5. Export the table and references into the landscape slide or the BD memo.

Evidence you can defend in a pipeline review

Claims traced to a record

A rival's announcement is not a registered endpoint. Open the citation, compare the registered primary endpoint with what was reported, and note where they differ. Verification proves the reference exists and supports the sentence. Your team still judges relevance and quality.

Rival activity by sponsor and country

The trial table shows sponsor, phase, status, enrollment, dates and locations, so you can see where a competitor is opening sites before the press release.

One workspace for the team

Research Team adds shared workspaces, comments and roles, so the clinical lead, the BD analyst and the medical director review the same evidence. Organization adds an audit log and invoicing.

Who gets value fastest

Small biotech teams that cannot justify an enterprise license usually start with Research Team and add seats as the program grows. The clinical trial intelligence platform guide covers that decision in more detail.

What clinical competitive intelligence costs with published prices

ClinicalEvidence carries no advertising. Plans are billed monthly or yearly and answers are pooled across the seats on the plan.

  • Clinician costs 49 USD per month or 24 USD per month billed yearly (288 USD). It includes 200 answers, 1 seat, up to 50 studies per answer, 5 alerts, CSV, RIS and BibTeX.
  • Research Team costs 199 USD per month or 99 USD per month billed yearly (1 188 USD). It includes 800 pooled answers, 3 seats, up to 200 studies per answer, 25 alerts, shared workspaces, comments, roles and CSV, XLSX, DOCX, RIS and BibTeX.
  • Organization costs 499 USD per month or 249 USD per month billed yearly (2 988 USD). It includes 2 000 pooled answers, 10 seats, up to 500 studies per answer, 100 alerts, bulk CSV, an audit log and invoicing.
  • Enterprise costs 1 490 USD per month or 745 USD per month billed yearly (8 940 USD). It includes 6 000 pooled answers, up to 50 seats, up to 1 000 studies per answer, 500 alerts and SAML SSO.

Full limits are on the pricing page.

Questions teams ask about pharma competitive intelligence tools

What are the best pharma competitive intelligence tools?

It depends on the scope. Enterprise platforms cover pipelines, deals, patents and forecasts under one license. For the clinical part, meaning competing trials, registered endpoints and status changes, ClinicalEvidence gives cited answers from three registries and PubMed with alerts, from 49 USD per month.

How do you track competitor clinical trials?

Search the registries for the indication and the rival drug, record phase, sponsor, endpoints, status and countries, then repeat on a schedule. ClinicalEvidence does this from one question, shows a filterable trial table and emails an alert when a new trial or status change matches your saved question.

Does ClinicalEvidence replace a pharma intelligence platform?

No. It does not track deals, patents, sales forecasts or analyst commentary. It replaces the manual registry work for competing trials and gives each sentence a source. Many teams keep a broad platform for the business view and use ClinicalEvidence for trial questions.

Does it use our confidential pipeline data?

No. ClinicalEvidence works on public registries and published literature. You do not upload internal documents or patient data to use it.

Can the whole team share one plan?

Yes. Research Team includes 3 seats and 800 pooled answers, Organization includes 10 seats and 2 000 pooled answers, and Enterprise supports up to 50 seats with SAML SSO.

Check what is registered against your program this week

Bring a real indication, open the citations and the trial table, and see whether the registry view answers your next pipeline question.